Grand Pharma Declares HKD 0.169 Final Dividend for FY 2025; Payment Slated for 30 June 2026

Bulletin Express03-26

Grand Pharmaceutical Group Limited (Grand Pharma) has announced a final ordinary dividend of HKD 0.169 per share for the financial year ended 31 December 2025, according to its filing with the Stock Exchange of Hong Kong.

Shareholders are scheduled to vote on the distribution at the annual general meeting on 5 June 2026. Subject to approval, the shares will trade ex-dividend on 12 June 2026.

The company’s Hong Kong share register will close for one day on 16 June 2026 to determine dividend entitlements. Investors must lodge share transfer documents with Computershare Hong Kong Investor Services by 16:30 on 15 June 2026.

Qualified shareholders on the 16 June 2026 record date are set to receive payment on 30 June 2026. The dividend will be paid in Hong Kong dollars at an exchange rate of HKD 1:HKD 1, and no withholding tax applies.

Grand Pharma’s board currently comprises four executive directors and four independent non-executive directors.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment